Synpolydactyly (SPD) is a distal limb anomaly characterized by incomplete digit separation and the presence of supernumerary digits in the syndactylous web. This phenotype has been associated with mutations in the homeodomain or polyalanine tract of the HOXD13 gene. We identified a novel mutation (G11A) in HOXD13 that is located outside the previously known domains and affects the intracellular half life of the protein.
INTRODUCTION
Establishment of anterior -posterior asymmetry in the limb bud (AP axis, from thumb to little finger) requires a regulatory network of signaling molecules whose expression is thoroughly coordinated in time and space (reviewed in 1,2). A small group of mesenchymal cells at the posterior margin of the developing limb bud-the zone of polarizing activity (ZPA)-acts as an organizer that initiates the specification of the anatomy of our hands and feet. Digit formation largely depends on the consecutive cascade of events initiated by the localized expression of Sonic Hedgehog (Shh) from the ZPA (3) . During the emergence of the limb bud, the expression of other patterning genes including dHand, Twist1 and the most 5 ′ members of the Hoxd gene cluster are activated in the posterior part of the limb bud and confer a positive feedback loop to sustain Shh expression (4, 5) . Meanwhile, the transcriptional repressor form of Gli3 (Gli3R) in the anterior mesenchyme restricts the expression of dHand, 5
′ Hoxd genes and Shh to the posterior part of the limb bud (6, 7) . The integration of the resulting opposing spatial gradient of Shh (posterior) and Gli3R (anterior) (8) and the kinetics of transcription of downstream target genes then further specifies the digit number and identity (reviewed in 1, 9) .
Defects in patterning genes such as GLI3 are known to cause congenital limb malformations in humans (10) (11) (12) . Synpolydactyly (SPD, MIM 186000) is an autosomal, dominantly inherited limb malformation syndrome categorized according to Temtamy and McKusick as 'type II syndactyly' (13) . SPD is manifested by fusion of the digits (syndactyly) in the mesoaxial line of the hands and in the postaxial part of the feet, particularly between the third and fourth finger and between the fourth and fifth toe, with a partially or completely duplicated digit in the syndactylous web (polydactyly) (14) . Additionally, it may be associated with brachydactyly, camptodactyly or clinodactyly of the fifth fingers and variable syndactyly of the second to fifth toes with middle phalanx hypoplasia (14) . The condition co-segregates with mutations in the homeobox transcription factor HOXD13 which has multiple functions during limb pattern formation (15, 16) .
The molecular mechanism of SPD has only been resolved for mutations residing in or near the protein's C-terminal homeodomain or within the N-terminal polyalanine tract † This study was approved by the local Ethical Board of the University Hospital Leuven. The work was performed at the University of Leuven. * To whom correspondence should be addressed. Tel: +32 16346196; Fax: +32 16346200; Email: przemko@med.kuleuven.be # The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com (reviewed in 17). In the former case, they result in failure to activate target genes (18, 19) , whereas in the latter, they induce ectopic cartilage formation in the interdigital mesenchyme (20, 21) . In this study, we describe a five-generation Pakistani family with a complex type of SPD caused by a glycine-to-alanine substitution at the N-terminal end of the HOXD13 protein. The elucidation of the genotype -phenotype correlation of this novel HOXD13 mutant is of particular interest since (i) no missense mutations have been described that reside at the N terminus of the protein, (ii) no N-terminal functional domains other than the HOXD13 polyalanine tract have been characterized to date and (iii) the proband is one of the few patients homozygous for an HOXD13 mutation (19) .
We show that the HOXD13(G11A) mutation does not alter the subcellular localization, the DNA-binding activity nor the transcription regulation function of HOXD13 in vitro, but instead causes a significant reduction in the protein half life when compared with the wild type. Our results suggest that the clearance of HOXD13 may not only be mediated by proteasomal degradation, as was postulated before (22) , but also involves a significant contribution of the lysosomal pathway.
In addition, we show that chick limb misexpression of mutated HOXD13 results in preaxial polydactyly or anterior ectopic cartilages in the autopod, recapitulating the human SPD phenotypes. Finally, our results indicate that this phenotype is possibly caused at the molecular level by an increase in affinity of HOXD13(G11A) for Gli3R and directing it into premature degradation. This results in depletion of Gli3R in the anterior limb bud leading to the formation of extra digits. Taken together, we identify a novel functional domain in HOXD13 and demonstrate an unappreciated function of HOXD13 in regulating digit number through its interaction with GLI3R.
RESULTS
A G11A missense mutation at the N terminus of HOXD13 causes a complex type of SPD in humans
We sequenced the exons of HOXD13 in a five-generation Pakistani family with two loops of consanguinity displaying complex type II SPD (OMIM 186000) (Fig. 1A) . Sequence analysis of the proband revealed a homozygous G-to-C mutation at position 32 of the coding sequence (Fig. 1B) resulting in a glycine-to-alanine conversion within an evolutionarily conserved region of HOXD13 with a hitherto unknown function. This G11A mutation has independently been identified by a Japanese group in a screening of patients with SPD (23) . The parents of the proband and the other affected family members were found to be heterozygous for the G11A mutation, while the mutation was not detected in 50 unrelated unaffected controls.
The mother of the proband displayed a mild SPD phenotype consisting of bilateral camptodactyly of the fifth fingers (Fig. 1C) and a discrete shortening and external rotation of the fourth and the fifth toes (Fig. 1D) . The proband was born with severe bilateral hand and foot anomalies with bilateral cutaneous and osseous syndactyly between the third and the fourth fingers and absent or rudimentary nails in the syndactylous web and in the fifth finger of the right hand ( Fig. 1E -H ). Radiographs revealed a complex type II SPD with clinical overlap with brachydactyly type A1 and B ( Fig. 1E and F) . The homozygous phenotype also includes broadening of the left metacarpals, a supernumerary digit in the syndactylous web that is fused to digit three, and bilateral osseous fusions of the distal phalanges. Furthermore, all fingers were short with small or absent middle phalanges and a rudimentary distal phalange of the first finger of the right hand. In the feet, the proband had short, medially deviated halluces and plantarflexion of the syndactylized mass of the fourth and the fifth toes (Fig. 1H ).
The N terminus of HOXD13 is essential to determine protein stability in vitro, a function that is impaired by the G11A mutation
The G11A mutation maps to a region of HOXD13 with a hitherto unknown function. To understand the molecular basis of the phenotype, we therefore investigated the effect of the mutation on various biochemical properties of the protein. We could not detect differences in subcellular localization, DNAbinding or transcriptional activity in immunofluorescence, electrophoretic mobility shift assays (EMSAs) or reporter assays, respectively (Supplementary Material, Fig. S1 ). Next, we investigated the intracellular half life of HOXD13(G11A) by arresting de novo protein synthesis using cycloheximide (CHX) and assessing the rate of degradation of wild-type or mutant HOXD13 by immunoblotting. As reported previously (18) , approximately half of the initial amount of wild-type HOXD13 was still detectable at 10 h after CHX treatment ( Fig. 2A and B) . However, the G11A mutation reduced the half life of HOXD13 by 5-fold ( Fig. 2A and B) . Importantly, another published HOXD13 mutation, HOXD13(G220V) (18), does not alter the stability of the protein to the same extent as the G11A mutant.
This prompted us to investigate whether the N-terminal part is necessary and sufficient to determine the stability of HOXD13 in vitro. We generated expression constructs encoding the first 78 amino acids of wild-type or mutant HOXD13 (including the polyA tract and the short preceding polyS and polyA tract) as green fluorescent protein (GFP) fusion proteins. The respective constructs, further referred to as HOXD13 N-term-78 (WT)-GFP and HOXD13 N-term-78 (-G11A)-GFP, respectively (Fig. 2C , left panel), were used for transient transfection in HEK293 cells. Twelve hours after transfection, the cells were exposed to CHX for 4 h, upon which the total cell number and the amount of GFP-positive cells was counted using fluorescent microscopy (Fig. 2D,  left panel) . Introduction of the G11A mutation significantly decreased the number of GFP-positive cells when compared with its wild-type counterpart (Fig. 2D, left panel) . These data suggest that the N-terminal part of HOXD13 is a protein region required for the correct turnover of the protein within cells, since inserting a G11A mutation accelerates protein degradation.
To map further the N-terminal domain necessary and sufficient to exert this function, we also tested shorter GFP fusion proteins in which only the first 31 amino acids of HOXD13 (excluding the polyA tract, including a short polyS stretch Figure 2D (right panel) suggest that the N-terminal stretch of 31 amino acids in HOXD13 is involved in determining protein stability in vitro. To confirm these data, we assayed the half life of the respective GFP fusion proteins, and found that the G11A mutation negatively influences the stability of the GFP fusion protein more than the wild type (Supplementary Material, Fig. S2 ). Taken together, we demonstrated that the integrity of the N-terminal 31 amino acids of HOXD13, excluding the polyalanine tract, is crucial to the stability of the protein, as shown by an accelerated degradation of its mutant (G11A) counterpart.
HOXD13 is degraded by the lysosomal pathway
Misfolded or mutated proteins are intracellularly degraded by two major pathways that are either lysosome-or proteasomedependent. Since the half life of the G11A mutant protein was significantly shorter than the wild type, we investigated which of the two main degradation pathways participated in that process. To accomplish that, HEK293 cells transiently overexpressing wild-type HOXD13 were treated with CHX to block protein translation and were simultaneously exposed to either lactacystin or chloroquine to block the proteasomal or the lysosomal pathway respectively. Following a 4h incubation period, protein levels in cell lysates were analyzed by SDS-PAGE and immunoblotting and quantified by digital image densitometry.
As shown in Figure 3 , there was a significant decrease of the wild-type HOXD13 protein level in cells treated with CHX alone or with CHX in combination with the proteasome blocker lactacystin. In contrast, protein levels of HOXD13 in cells treated with a combination of CHX and a lysosome blocker (chloroquine) were largely unaffected (Fig. 3) , indicating that wild-type HOXD13 was degraded through the lysosomal pathway. Similar results were obtained with MG132 or NH 4 Cl as a proteasome or lysosome blocker respectively (data not shown).
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Misexpression of HOXD13(G11A) causes patterning defects in the developing chick limb
To further explore the molecular basis of SPD induced by the HOXD13(G11A) mutation, we used the RCAS retroviral system to misexpress wild-type or mutant HOXD13 in the developing chick limb (reviewed in 24). Replication-competent RCASBP(A) retroviral vectors expressing full-length HOXD13(WT) or HOXD13(G11A) were injected in ovo into the presumptive right hind limb field of stage Hamburger Hamilton (HH) 10 developing chick embryos (25) , thereby leaving the left uninjected limb as a contralateral control. Injected embryos were harvested at stage HH34 and skeletal morphology was assessed by Alcian blue (for cartilage) and Alizarin red staining (for mineralized tissue including bone).
In agreement with previous observations (18, 26, 27) , misexpression of wild-type HOXD13 induced (i) a marked shortening of the cartilaginous elements of the stylopod and zeugopod, (ii) a delay in ossification and (iii) a premature articulation or fusion of the fibula to the fibulare ( Fig. 4A and B). The resulting developmental defects were classified as mild, moderate or severe according to the length of the tibia, as previously described [Supplementary Material, Fig. S3B and (18)]. Of the embryos displaying limb defects (n ¼ 17), 29% showed a mild, 42% a moderate and 29% a severe phenotype when misexpressing wild-type HOXD13 ( Fig. 4A and D) . Misexpression of HOXD13(G11A) induced similar skeletal abnormalities, but the embryos (n ¼ 37) consistently showed more severe phenotypes ( Fig. 4B) , with a phenotype distribution of 11% for mild, 43% for moderate and 46% for severe phenotypes respectively ( Fig. 4B and D ). In addition, as reported previously (18, 26, 27) , misexpression of HOXD13(WT) did not produce phenotypic changes in the autopod, where endogenous chicken Hoxd13 is normally expressed. Intriguingly, in contrast to the phenotypes induced by the misexpression of wild-type HOXD13, misexpression of HOXD13(G11A) induced anterior ectopic cartilage or digit formation in 32% of the injected embryos (Fig. 4C ).
HOXD13(G11A) produces distal limb malformations by modulating the interplay between HOXD13, dHand and Gli3 prior to Shh induction in the ZPA Thus, misexpression of HOXD13(G11A) in the developing chick limb induces phenotypes similar to those induced by the same mutation in SPD patients (including preaxial polydactyly or ectopic cartilage formation). In order to facilitate the investigation of the pathogenic mechanism, we co-infected developing chick limbs with RCASBP(B)-GFP and wild-type or mutant RCASBP(A)-HOXD13. This strategy allowed us to study only the limbs that display a uniform expression pattern of GFP prior to the detection of the first macroscopic signs of the skeletal phenotype caused by HOXD13 misexpression (see Supplementary Material, Fig. S3A for details) .
The induction of extra anterior digits are frequently associated with ectopic anterior Shh mRNA expression and/or anteriorly extension of the dHand mRNA expression domain (28, 29) . Thus, following selection of co-injected embryos for uniform GFP expression in the right hind limb only (n ¼ 20), the effect of HOXD13(WT) or HOXD13(G11A) misexpression on the expression pattern of Shh and dHand was examined by whole-mount in situ hybridization (WISH) at stage HH21. Misexpression of wild-type or mutant HOXD13 did not have a detectable effect on the apparent level or location of Shh mRNA expression (i.e. no detectable Shh expression in the anterior part of the limb in 100% of the analyzed embryos (n ¼ 10; Fig. 5 , upper panels). As anticipated (18) however, misexpression of wild-type HOXD13 induced ectopic dHand expression in 60% of the analyzed embryos (n ¼ 5; Fig. 5 , lower panels). This effect was more pronounced in embryos injected with RCAS-HOXD13(G11A) (n ¼ 5), which, in extreme cases, resulted in expansion of the dHand expression domain throughout the entire injected hind limb (Fig. 5 , lower panels).
HOXD13(G11A) sequesters Gli3R through a direct interaction, followed by degradation of the protein complex
During normal limb pre-patterning, dHand is transcriptionally repressed by the repressor form of Gli3 (Gli3R) (29) . Since the expression domain of dHand was anteriorly expanded upon HOXD13 misexpression, it could be possible that HOXD13 (wild type and even more so the G11A mutant) is titrating out the available GLI3R that results in preaxial polydactyly. To test this hypothesis, we carried out a co-immunoprecipitation (co-IP) and competition experiment of HOXD13(G11A) in the presence of HOXD13(WT) and limiting amounts of Gli3R (Fig. 6) . Briefly, HEK293 cells were co-transfected with myctagged HOXD13(WT), together with limiting amounts of Gli3R and increasing amounts of either wild-type or mutant HA-tagged HOXD13 (Fig. 6A) . We then performed co-IP to assess the capability of the HA-tagged HOXD13 constructs to compete with the myc-tagged HOXD13(WT) for binding to Gli3R. As described previously (30) , wild-type HOXD13 and Gli3R co-immunoprecipitated specifically and selectively when co-expressed in HEK293 cells (Fig. 6B) . We found that the HA-tagged G11A mutant is able to compete with myc-tagged HOXD13(WT) for binding to Gli3R (Fig. 6B) . These results demonstrate that the G11A mutant binds Gli3R with a higher affinity than wild-type HOXD13.
These results, in conjunction with the strong reduction of the half life of the G11A mutant, led us to speculate that HOXD13(G11A) might sequester Gli3R into degradation. To verify this assumption, we determined the half life of Gli3R in the presence of wild-type or mutant HOXD13 respectively. We could show that HOXD13(G11A) significantly reduced the half 
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life of Gli3R in vitro when compared with the wild type. Altogether, these findings indicate that HOXD13(G11A), through a direct interaction, sequesters Gli3R and that this complex is subsequently targeted for degradation.
DISCUSSION
The importance of the SHH/GLI3R loop during development of the limb in general and of the autopod in particular has been extensively documented (29, 31) . One of the proposed functions of the SHH signaling cascade is the imposition of pentadactyly on the developing autopod (6, 31) . The interaction of HOXD13 with GLI3R, a component of that pathway, has been described before (30) but the in vivo biological significance of that interaction has not been fully elucidated. Our results show that HOXD13, through its interactions with GLI3R, fine tunes the number of the digits. This interaction is so strong that changes in the protein half life of HOXD13 have a direct effect on the availability of GLI3R. Our work corroborates the earlier work of Chen et al. (30) showing that HOXD13, also through the interaction with GLI3R, participates in the regulation of the pentadactyly. We postulate that the HOXD13 -GLI3R interaction is one of the primary regulatory signals delineating the autopod field and the number of skeletal elements within it.
The importance of HOXD13 in limb development has been illustrated before since distinct mutations in the HOXD13 gene are associated with skeletal malformations in both humans and mice (15, 16 and reviewed in 17). All SPD-causing HOXD13 mutations identified so far have been mapped to the N-terminal polyalanine tract or to the C-terminal homeodomain, causing typical or atypical features of SPD, respectively (reviewed in 17). The molecular basis of these phenotypes has recently been investigated (19) (20) (21) . There are however many intriguing aspects of HOXD13 biology to be unraveled, including the characterization of other functional domains for instance through the analysis of (missense) mutations outside of the polyalanine tract or the homeobox.
A complex type of SPD in humans is associated with a novel G11A missense mutation at the N terminus of HOXD13
We present a novel case of SPD linked to a G11A missense mutation in a previously uncharacterized region of HOXD13. Taking into consideration the classification of SPD phenotypes published by Malik et al. (14) , we conclude that affected family members present some of the canonical features of SPD, in particular the severe phenotype of the homozygous proband including the cutaneous and osseous fusions in hands and feet and the involvement of metacarpals and metatarsals. In addition to the classical features of SPD, heterozygous individuals showed some minor variants frequently associated with SPD, including camptodactyly or clinodactyly of the fifth fingers, and brachydactyly of the fourth and the fifth toes. Finally, there were also signs of overlap with Brachydactyly type B since the proband displayed rudimentary or hypoplastic distal phalanges and absent or underdeveloped nails.
In general, the SPD phenotypes of the affected family members correlate with the traits of the severe end of the phenotypic spectrum, with the homozygous phenotype being HOXD13 protein stability is determined by its N terminus and is negatively affected by the G11A mutation
Proteins, in particular those with regulatory activity (as opposed to the structural ones), are degraded upon completion of their function. For instance, transmembrane receptors, ligands or transcription factors are degraded, sometimes rapidly, in order to fine-tune their regulatory activities. Therefore, it is of great interest to identify and characterize mechanisms regulating the intracellular pool size of the proteins. One of the best described cases is the intracellular processing and degradation of beta-catenin, a transcriptional co-activator of Wnt signaling (34) . In the case of HOX transcription factors, and in particular HOXD13, very little data considering the intracellular processing and the protein domains involved in that process is currently available (22, 35) . Molecular analysis of the HOXD13(G11A) mutation, located in an uncharacterized region of the protein, thus provides a tool to gain insight into functional domains of HOXD13 other than the homeodomain or the polyalanine tract. We were unable to detect any difference in DNA-binding capacity or transcriptional activity between wild-type and mutant HOXD13. However, we discovered that the G11A mutation causes a dramatic reduction of the half life of HOXD13, unlike any other published HOXD13 mutations (18) . By determining the half life of HOXD13-GFP fusion proteins, we also demonstrated that the N-terminal 31 amino acids of HOXD13, excluding the polyalanine tract, are necessary and sufficient to determine the protein stability in vitro. A significant aspect of this function is most likely to be mediated by the first stretch of amino acids since we could show that the G11A mutation destabilizes the rest of the protein significantly more than its wild-type counterpart. Thus, in addition to the previously characterized polyalanine tract and the homeodomain, these findings reveal the existence of a novel functional domain within the N terminus of HOXD13 that, in particular when mutated, dramatically decreases the intracellular half life of the protein.
The HOXD13(G11A) mutation could affect protein stability in at least two ways. It could create a novel protease target site and further studies will be required to determine the exact target sequence. Alternatively, it is possible that the G11A mutation alters the structural conformation of HOXD13 leading to aggregation and accelerated degradation of the protein. It has been reported that HOXD13 mutants, such as HOXD13(+14 Ala), carrying a 14-residue polyalanine tract expansion mutation, and HOXD13(G220V) are prone to form cytoplasmic aggregates in addition to its normal nuclear localization (18, 22) . We could not find a difference in subcellular localization between wild-type and the HOXD13(G11A) mutant. It is unclear whether these results imply that the mutant is not retained in cytosolic inclusions or whether it does form cytoplasmic aggregates, but at low production rates so that they do not overload the protein's degradation machinery. The latter mechanism has been shown by Albrecht et al. (22) for HOXD13 polyalanine tract expansion mutations. Interestingly, this group postulates that polyalanine tract expansion mutants, as many other misfolded proteins, form cytoplasmic aggregates that are mainly degraded by the proteasome.
It is the interconnection of three main pathways that is essential for the management of misfolded proteins and subsequent cell viability (36): (i) the molecular chaperone machinery-including heat shock proteins (hsp)-assists in proper protein folding, (ii) the proteasome pathway degrades misfolded proteins and (iii) the lysosome pathway delivers protein aggregates to autophagy for clearance (36) . It should be noted however that in fact these pathways are not mutually exclusive (36, 37) , and several lines of evidence point toward a combined mechanism of action. Indeed, Albrecht et al. (22) and Kopito (38) showed that the amorphous aggregates are different from classical protein aggregates that are wellstructured or associated with aggresome formation within the so-called microtubule-organizing center. Once aggregated, misfolded proteins are not efficiently degraded by proteasomes (36) . This, in accordance with our data that clearly show that HOXD13 is degraded through the lysosomal pathway, could therefore indicate that both proteasomal or lysosomal degradation is involved in HOXD13 degradation. Moreover, it remains to be resolved whether the G11A mutation, like other Hoxd13 mutants (39), exerts a dominant-negative effect over the wild-type protein, confirming a gain-of-function pathogenic mechanism.
Misexpression of HOXD13(G11A) induces patterning defects in the chick limb by disturbing the anterior Gli3R function
Human limb malformations caused by HOX gene mutations have been studied in the chick model system by misexpressing the mutant genes from replication-competent RCAS retroviruses (18, 27, 40) . To investigate the in vivo effect of the G11A mutation during chick limb development, we implemented an adapted, dual RCAS injection strategy in which we combined two RCAS viruses expressing distinct types of envelope glycoproteins in order to bypass receptor interference (24) and superinfect chicken cells simultaneously with both HOXD13 and GFP. This enables the selection of embryos that express the transgenes uniformly and exclusively throughout the right hind limb, thereby enriching the pool of embryos representing the severe end of the phenotypic spectrum. This technique thus allows a significant reduction in intra-assay variability and thereby opens new avenues for the future study of the in vivo effects of limb patterning genes with improved accuracy.
It should be noted that RCAS-based HOXD13 misexpression in the chick reproduces some aspects of human SPD (18, 26, 27) . Misexpression of wild-type HOXD13 has been demonstrated to cause limb defects mainly at the level of the stylopod, zeugopod and proximal autopod, where endogenous chicken Hoxd13 is not expressed (18, 26, 27) . Indeed, HOXD13(WT) misexpressing embryos displayed a delay in ossification, reductions in size of the zeugopodal and stylopodal skeletal elements, sometimes
associated with a premature articulation or fusion of the fibula to the fibulare, which corroborates previously published data (18, 27) . These findings are in contrast with the polydactyly phenotypes of wild-type Hoxd13 misexpression in mice (41) . The absence of any phenotypic changes in the distal autopod in the chick are presumably correlated with the level of HOXD13(WT) misexpression. When misexpressing HOXD13(G11A), the same phenotypic classes as upon misexpression of wild-type HOXD13 were observed [mild, moderate or severe, Supplementary Material, Fig. S3B and (18) ], but with a higher incidence of moderate-to-severe phenotypes. Interestingly, the G11A mutation induced anterior ectopic cartilage or digit formation in one-third of the injected embryos. These findings suggest that the G11A mutation might act through a gain-of-function mechanism, since it also affects the distal autopod in contrast to the wild-type or other mutants (18, 26, 27) . This particular mutation is thus powerful enough to phenocopy typical human SPD phenotypes in the chick, providing a novel tool to study the molecular basis of the disorder in detail.
It has been generally accepted that ectopic anterior Shh signaling is a major cause of preaxial polydactyly in mice, chicks and humans (42) . However, deregulation of genes involved in prepatterning of the limb prior to ZPA establishment and Shh induction, including an imbalance of the mutual antagonism of Gli3R (anterior) and dHand (posterior), has also been found to be implicated in ectopic digit development (29) . To explore the molecular mechanism by which the G11A mutation induces the preaxial ectopic digit or cartilage formation, we examined the expression pattern of both dHand and Shh using WISH on stage HH21 embryos. As anticipated (18) , misexpression of wild-type HOXD13 resulted in ectopic expression of dHand. This effect was even more pronounced in HOXD13(G11A) misexpressing embryos which, in extreme cases, resulted in a complete failure to posteriorly restrict dHand leading to expansion of its expression domain throughout the entire injected hind limb. These results suggest that HOXD13(G11A), in contrast to the wild type, induces preaxial polydactyly by upregulating dHand expression above a certain threshold in the anterior part of the limb bud. These phenotypes are in agreement with loss-of-function mutations in Lst (Alx42/2) (43) or Xt (Gli32/2) mice (44) , as well as with gain-of-function experiments with dHand (28) or other 5 ′ Hoxd genes (4, 45) . In fact, these phenotypes are attributed to ectopic Shh activity in the anterior mesenchyme. However, in our experiments, we were not able to detect ectopic Shh mRNA expression in both wild-type or mutant injected limbs. The same observations were made by Fernandez-Teran et al. (28) in embryos misexpressing dHand. It could be argued that the Shh pathway is activated either indirectly, without induction of Shh itself, or transiently and at levels below the detection limit of WISH (28) . The latter effect has also been observed in other recent studies (46) as well as in the Gli3
Xt/Xt /Hoxd11-13 2/2 mouse, in which ectopic activation of Shh due to a combined loss of Gli3 and Hoxd11-13 function is usually small, transitory and sometimes difficult to detect (6) . In addition, ectopic Shh activation in Gli3 2/2 or in Tg-Hoxd12;Gli3 +/2 limbs is also thought to represent a secondary 'readout' of Hedgehog pathway activation via reduced Gli3R, rather than a direct cause for the polydactyly phenotypes (30) .
We favor the hypothesis that the occurrence of preaxial polydactyly in HOXD13(G11A) misexpressing embryos occurs prior to Shh signaling and involves deregulation of the Gli3 repressor form. The mutual antagonistic action of Gli3R (anterior) and dHand and the 5 ′ Hoxd genes (posterior) is indispensable for pre-patterning of the limb along the AP-axis (29) . Gli3R is required for posterior restriction of both dHand and 5 ′ Hoxd genes, and is thought to carry out a protective function against the prevalence of posterior Hox genes (15) . Furthermore, Gli3R has been shown to physically interact with Hoxd12 and Hoxd13 (30) . In turn, dHand directly binds to Hoxd13, and both proteins induce Shh expression by binding its upstream cis-regulatory region (47, 48) . Consequently, we hypothesize that the mechanism by which short-lived HOXD13(G11A) mutant decreases the intracellular levels of GLI3R is through a direct interaction resulting in premature degradation of GLI3R. To verify this assumption, we carried out a co-IP competition experiment of HOXD13(G11A) in the presence of HOXD13(WT) and limiting amounts of Gli3R, and found that the mutant indeed has a higher affinity for Gli3R than the wild type. Furthermore, we could show that HOXD13(G11A) reduces the in vitro half life of Gli3R more than that of the wild type. These findings open the possibility that HOXD13, through a direct interaction, sequesters Gli3R into protein heterodimers that are subsequently targeted for degradation. Since the G11A mutant has a higher affinity for Gli3R than its wild-type counterpart, this property could explain the dominant effect of the mutation and the heterzygous patient phenotypes.
Hence, we propose a molecular explanation for the phenotype induced by the HOXD13(G11A) mutation where mutated HOXD13 depletes the anterior levels of Gli3R by directing it into degradation (Fig. 6D) . A premature decrease in GLI3R consequently results in the ectopic anterior induction of dHand expression (Fig. 6D) . Accordingly, the absence of ectopic digit formation when misexpressing HOXD13(WT) is likely attributable to a threshold effect, by which sufficient amounts of Gli3R remain to posteriorly restrict dHand expression to some extent. It should be noted however, that the enhanced binding of Gli3R by HOXD13(G11A) may also have an effect on Gli3R function besides affecting its stability. Both mechanisms are not necessarily mutually exclusive, and they could therefore both contribute to the G11A phenotype.
Taken together, our results suggest that the SPD in patients harboring an HOXD13(G11A) mutation is caused by depletion of GLI3R levels during early limb development through intracellular protein degradation. Furthermore, these findings argue in favor of a more prominent role of HOXD13 during prepatterning of the limb, co-operating at the same level of dHand in the antagonism of anterior Gli3R function and establishment of anterior-posterior polarity in the developing limb bud.
MATERIALS AND METHODS

Patient evaluation and mutation analysis
The family of Pakistani origin was identified following referral to the Clinical Genetics Unit, Birmingham Women's Hospital, UK. The proband and his mother were clinically examined,
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and radiographs of both hands and feet were obtained. Venous blood samples for genomic DNA extraction were obtained from the proband, both parents and other family members, as well as 50 unaffected controls, with their informed consent and approval from the local ethical committee. To screen for mutations in the HOXD13 gene, the coding region was amplified by PCR in four segments as described in (49) . Cycle sequencing of the amplified fragments was performed on an ABI 377 automated sequencer (Applied Biosystems) either directly (Applied Biosystems Prism Dye Terminator Kit) or after cloning the PCR fragments into pCR-Script (Stratagene).
Expression constructs
The Xpress-tagged pcDNA3.1-Gli3R expression construct was kindly provided by S. Mackem (NIH, USA). pSG5-HOXD13(+14Ala) was described before (18) . pcDNA3.1-HOXD13(WT) was generated by cloning the human HOXD13 coding sequence into the EcoRI/BamHI sites of pBS-SK+ vector (Stratagene) and subsequent subcloning into the HindIII/ XbaI sites of pcDNA3.1(+) (Invitrogen). HA-tagged HOXD13(WT) expression constructs were produced by subcloning the open reading frame (ORF) of wild-type HOXD13 into the BamHI/XbaI sites of pcDNA3.1-HA(C) (Invitrogen). The G11A mutation was introduced by PCR mutagenesis using the primers 5 ′ -ATGCGGATCCATGAGCCGCGCCGGGAGCTGGGAC ATGGACGCGCTGCGGGCAGA-3 ′ and 5 ′ -CCATGTACTTC TCCACGGGAAAGCCTCCCAGCGAGGCGTGC-3 ′ . The amplified fragment was sequence-verified and substituted for the corresponding wild-type BamHI/NotI within pcDNA3.1-HOXD13(WT) and pcDNA3.1-HA-HOXD13(WT). Myc-HIStagged pcDNA3.1-HOXD13(WT) was generated by amplifying the ORF of HOXD13(WT) using primers 5
′ -ATATATGGA TCCATGAGCCGCGCCGG-3 ′ and 5 ′ -TATATATCTAGAG GAGACAGTA-TCTTTGAGCTTGGAG-3 ′ . The amplicon was then cloned into the BamHI/XbaI sites of pcDNA3.1-myc-HIS(A) (Invitrogen). Plasmids expressing GFP fusion proteins were obtained by cloning the N-terminal 78 or 31 amino acids of HOXD13 translationally in frame with the eGFP coding sequence in the pEGFP-N1 vector (Clontech). For this, the N-terminal fragments of the wild-type or mutant HOXD13 coding sequence were amplified by PCR using 5 ′ -TATAT AAGCTTATGAGCCGCGCCGGG-3 ′ as a forward primer and reverse primers 5 ′ -ATATGGATCCACCGATGAGGAGGAG GAAGAGGC-3 ′ and 5 ′ -TATATGGATCCCCGG-GGTACGC AAAG-3 ′ for HOXD13 N-term-31 and HOXD13 N-term-78 , respectively. The respective amplicons were subsequently cloned into the HindIII/BamHI sites of pEGFP-N1 to generate pEGFP-HOXD13 N-term-31 and pEGFP-HOXD13 N-term-78 , respectively. An RCASBP(A) and RCASBP(B) avian retroviral vector for the expression of GFP was kindly provided by M. Logan (London, UK). RCAS constructs expressing human HOXD13(WT) and HOXD13(G11A) were generated by amplifying the ORF of full-length wild-type or mutant HOXD13 by PCR using primers 5 ′ -TATATAGACGTGCAGCCGACCACCAT GAGCCGCGCCGGGAGCTG-3 ′ and 5 ′ -TCTCAG-ATAGG TTCGTAGCAGCCG-3 ′ . The amplicons were cloned into the BmgBI site of the shuttle vector pSLAX13-HOXD13(WT), followed by subcloning of the entire ClaI-adapter fragment into the ClaI-linearized retroviral pRCAS-BP(A) vector (50) .
Antibodies and reagents
Commercially available antibodies were mouse monoclonal HA tag antibody (Eurogentec), rabbit polyclonal HOXD13 antibody (kind gift of S. Mackem, NIH, USA), rabbit polyclonal 6xHIS tag antibody (Abcam), c-myc monoclonal mouse antibody (Santa Cruz Biotechnology), affinity purified rabbit polyclonal Gli3 antibody (gift of S. Mackem), rabbit IgG Trueblot (eBioscience), mouse monoclonal GAPDH antibody (Ambion), rabbit polyclonal GFP antibody (gift of M. Quattrocelli, Leuven, Belgium), secondary HRP-conjugated goat anti-mouse (Jackson), Alexa Fluor 488-coupled donkey anti-mouse (Molecular Probes). Following reagents were used: CHX (Sigma), NH 4 Cl (Merck), lactacystin (Sigma), chloroquine (Sigma), MG132 (Merck).
Cell culture and transfections
For overexpression studies, immortalized chicken embryonic fibroblast (DF1) cells, COS7 cells or HEK293 cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with glucose (4.5 g/l, Gibco-Invitrogen) with 10% (v/v) fetal bovine serum (Gibco-Invitrogen), antibiotics/antimycotics (100 U/ml penicillin, 100 mg/ml streptomycin, 0.25 mg/ ml amphotericin B; Gibco-Invitrogen) and 1% (v/v) sodium pyruvate (Gibco-Invitrogen). All cultures were maintained at 378C, 5% CO 2 and 95% humidity. Transient transfections were carried out using Lipofectamine LTX with Plus Reagent according to the manufacturer's instructions (Invitrogen).
Microinjection and phenotypic analysis of developing chick embryos
Virus production, concentration and titration of the viral supernatants was performed as described elsewhere (18) . Microinjection of stage HH10 chick embryos and phenotypic analysis (skeletal staining) was performed as outlined before (18, 50) . For the dual RCAS injection, RCASBP(B)-GFP was mixed with either wild-type or mutant RCASBP(A)-HOXD13 at a 3:7 ratio and subsequently injected as described previously (18, 50) . WISH using digoxigenin-labeled anti-sense RNA probes was performed according to Salsi et al. (51) . Following antisense probes were used: Shh (kind gift of M. Logan, London, UK) and dHand. Tibia measurements, phenotype classification and statistics were performed as previously published (18) .
Protein stability assay, protein degradation assay, immunofluorescence and FACS The protein stability assay was performed according to Fantini et al. (18) . To determine the subcellular localization, cells were fixed in methanol and analyzed by immunofluorescence according to standard protocols. To determine the intracellular degradation pathway, HEK293 or DF1 cells were transiently transfected with wild-type HOXD13 expressing constructs. Twelve hours after transfection, the cells were trypsinized Cells were co-transfected with a plasmid encoding red fluorescent protein (kind gift of S. Wilson) to normalize for the transfection efficiency. Twelve hours after transfection, cells were trypsinized and replated into a six-well plate, followed by CHX treatment for 8h at a final concentration of 200 mg/ml. The total cell number and the amount of GFP-positive cells were counted by two independent investigators using fluorescent microscopy and normalized to the amount of RFP-positive cells to compensate for differences in transfection efficiency. Alternatively, the ratio of GPF-positive cells to the total cell count was established by FACS analysis on an FACSCanto cytometer using the BD FACSDiva 5.0 software (both from BD Biosciences). Briefly, following trypsinization and centrifugation at 1050 rpm for 10 ′ , cells were resuspended and fixed in 2% paraformaldehyde in PBS prior to FACS analysis.
Co-immunoprecipitation
Co-IP was performed by co-transfecting a 10-cm dish of HEK293 cells with 50 ng (limiting amounts) of Gli3R, 200 ng of myc-HIS-tagged HOXD13(WT) and increasing amounts (50, 200 or 500 ng) of HA-tagged wild-type or mutant HOXD13. The DNA content was adjusted to 1 mg using empty pcDNA3.1 vector (Invitrogen). Twenty-four hours after transfection, cells were lysed in 400 ml of IP buffer [10 mM HEPES (pH 7.5), 1 mM EDTA, 250 mM NaCl, 0.5% NP-40, protease inhibitors] on ice with trituration. Cell lysates were centrifuged at 5000 rpm for 5 ′ , and 600 ml of lysate was immunoprecipitated with 2 mg of anti-Xpress tag antibody with gentle rotation at 48C. Following 3 h of incubation, immunoprecipitates were coupled overnight to Protein G Sepharose beads with gentle rotation at 48C. Beads were washed with IP buffer and protein solubilization was performed by adding a 'bead volume' of 2× LDS sample buffer (Invitrogen) supplemented with 0.1 M DTT. Immunoprecipitates were analyzed by immunoblotting on a 12% Bis-Tris gel.
Electrophoretic mobility shift assay
Full-length HOXD13(WT), HOXD13(G11A) and HOXD13(I47L) were synthesized in vitro using the TNT-coupled transcription/translation system (Promega) and used in EMSAs as described in (27) together with the following oligonucleotide probes: 5 ′ -GCCGTCCGTT-TTATTG GGGACACA-3 ′ and 5 ′ -GCCGTCCGTTTTACGAGGGAC ACA-3 ′ . The total amount of reticulocyte lysate in each binding reaction was adjusted to normalize for the translated protein content.
Luciferase reporter assays
Luciferase reporter assays using pT81(TTAT) 6 reporter constructs were performed as described elsewhere (18) .
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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